Chemotherapy induced phlebitis experienced by women with breast cancer following administration of epirubicin using a volumetric infusion pump: an observational study

Williams, Natasha; Williams, Edgar M.; Roberts, Rosie

doi:10.1016/j.ejon.2023.102322

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 1 , 2 , 3 Although immunotherapy has provided new opportunities for the treatment of cancer patients in recent years, surgical resection supplemented by chemoradiotherapy is currently mainly used in the clinical treatment of cancer, and chemotherapeutic drugs have greater vascular damage and long‐term frequent intravenous infusion stimulates blood vessels, which can easily cause complications such as phlebitis. 4 , 5 Port is an intravenous infusion device implanted subcutaneously for long‐term indwelling, which can be repeatedly punctured for 2000 times and is suitable for long‐term application in cancer patients. It can effectively reduce the pain caused by repeated puncture of peripheral veins in patients.…”

Section: Introductionmentioning

confidence: 99%

Effect of skinfold thickness on arm venous access port in cancer patients

Liu,

Li,

Liu

et al. 2023

Skin Research and Technology

View full text Add to dashboard Cite

BackgroundCurrently, skinfold thickness in studies on arm venous access ports and the effect of venous access port application are unknown.Materials and MethodsA total of 256 cancer patients who underwent primary venous access port placement in the Fourth Hospital of Hebei Medical University from September 2022 to March 2023 were selected as the study subjects. Two hundred fifty‐six patients were divided into normal skinfold thickness group and high skinfold thickness group according to skinfold thickness. The success rate of primary catheterization of arm venous port catheterization, catheterization operation time, catheterization length and incidence rate of adverse reactions were compared.ResultsThere was no significant difference in the basic data between the two groups. There was no significant difference in the success rate of primary catheterization between the two groups (p > 0.05), the catheterization operation time in the normal skinfold thickness group was significantly lower than that in the high skinfold thickness group (p < 0.05), the total length of the implanted catheter in the normal skinfold thickness group was significantly lower than that in the high skinfold thickness group (p < 0.05), and the incidence of adverse reactions in the normal skinfold thickness group was significantly lower than that in the high skinfold thickness group (p < 0.05).ConclusionIn cancer patients, skinfold thickness can significantly affect the application effect of arm venous port, and normal skinfold thickness for arm venous port has shorter operation time, total length of implanted catheter and lower incidence of adverse reactions.

show abstract